Autologous haematopoietic stem cell transplantation for Crohn's disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party

Autologous haematopoietic stem cell transplantation for Crohn's disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party

Autologous haematopoietic stem cell transplantation (AHSCT) is an emerging therapeutic option for refractory Crohn’s disease (CD). The ASTIC trial of AHSCT failed to meet its stringent composite primary endpoint, but 1-year follow-up data demonstrate sustained efficacy. The real-world use and outcom...

Full description

Bibliographic Details
Main Authors:	Brierley, C, Castilla-Llorente, C, Labopin, M, Badoglio, M, Rovira, M, Ricart, E, Dierickx, D, Vermeire, S, Hasselblatt, P, Finke, J, Onida, F, Cassinotti, A, Satsangi, J, Kazmi, M, Lopez-Sanroman, A, Farge, D, Travis, S, Hawkey, C, Snowden, J
Format:	Conference item
Published:	Oxford University Press 2018

Similar Items

Autologous haematopoietic stem cell transplantation (AHSCT) for Crohn's disease (CD): A retrospective study of outcomes from the EBMT autoimmune diseases working party (ADWP)
by: Brierley, C, et al.
Published: (2017)

Autologous haematopoietic stem cell transplantation for Crohn’s disease: A retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation
by: Brierley, CK, et al.
Published: (2018)

Clinical and endoscopic improvement following haemopoietic stem cell transplantation on behalf of the Autoimmune Diseases Working Party of the EBMT
by: Hawkey, C, et al.
Published: (2013)

Autologous haematopoietic stem cell transplantation in CLL: first results of an EBMT randomized trial comparing autotransplant versus wait and watch
by: Michallet, M, et al.
Published: (2010)

Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties
by: Raffaella Greco, et al.
Published: (2019-07-01)

Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
by: Alois Gratwohl, et al.
Published: (2019-10-01)

In utero haematopoietic stem cell transplantation
by: C Troeger, et al.
Published: (2006-08-01)

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
by: Annalisa Ruggeri, et al.
Published: (2018-03-01)

Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)
by: Fiona Roberts, et al.
Published: (2020-12-01)

Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT
by: Benedicte Neven, et al.
Published: (2020-01-01)

Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study.
by: Snowden, J, et al.
Published: (2019)

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
by: Jaime Sanz, et al.
Published: (2020-05-01)

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
by: Simona Piemontese, et al.
Published: (2019-07-01)

Haematopoietic stem cell transplantation in Switzerland
by: Swiss Medical Weekly
Published: (2006-01-01)

Standardizing haematopoietic cell transplants in China
by: Robert Peter Gale
Published: (2018-03-01)

Haematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
by: M. A. Slatter, et al.
Published: (2023-09-01)

GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
by: Frédéric Baron, et al.
Published: (2023-02-01)

Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
by: Robert David Sandler, et al.
Published: (2020-03-01)

IN UTERO HAEMATOPOIETIC STEM CELL TRANSPLANTATION (IUHSCT)
by: Maria Concetta Renda, et al.
Published: (2009-12-01)

Acute symptomatic seizures during haematopoietic stem cell transplantation
by: Ya. B. Skiba, et al.
Published: (2021-04-01)

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT
by: Arnon Nagler, et al.
Published: (2023-05-01)

Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT
by: Nicole Santoro, et al.
Published: (2018-04-01)

Low pre-transplant levels of mannose-binding lectin are associated with viral infections and mortality after haematopoietic allogeneic stem cell transplantation
by: M. Puente, et al.
Published: (2019-11-01)

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
by: Nicole Santoro, et al.
Published: (2017-05-01)

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party
by: Maria Teresa Cencioni, et al.
Published: (2022-02-01)

Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
by: Federica Giannotti, et al.
Published: (2018-08-01)

Cross-cutting view of current challenges in paediatric solid organ and haematopoietic stem cell transplantation in Europe: the European Reference Network TransplantChild
by: P. Jara, et al.
Published: (2020-01-01)

Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT
by: Arnon Nagler, et al.
Published: (2023-09-01)

Quality of life after haematopoietic stem cell transplantation in a multiracial population
by: Bee, P.C., et al.
Published: (2011)

Immune reconstitution following haematopoietic stem cell transplantation.
by: Davison, G, et al.
Published: (2000)

The role of the thymus in allogeneic haematopoietic stem cell transplantation
by: Krenger, W, et al.
Published: (2010)

The role of the thymus in allogeneic haematopoietic stem cell transplantation
by: Krenger, W, et al.
Published: (2010)

Noninfectious pulmonary complications of haematopoietic stem cell transplantation
by: Samran Haider, et al.
Published: (2020-06-01)

DEFIBROTIDE TREATMENT IN PAEDIATRIC PATIENTS WITH SEVERE/VERY SEVERE VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HAEMATOPOIETIC CELL TRANSPLANTATION: DEFIFRANCE INTERIM RESULTS
by: V. Gandemer, et al.
Published: (2020-11-01)

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
by: Jaime Sanz, et al.
Published: (2021-05-01)

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN CLL: FIRST RESULTS OF AN EBMT RANDOMIZED TRIAL COMPARING AUTOTRANSPLANT VERSUS WAIT AND WATCH
by: Michallet, M, et al.
Published: (2010)

S238: MATCHED RELATED VERSUS UNRELATED VERSUS HAPLOIDENTICAL DONORS FOR ALLOGENEIC TRANSPLANTATION IN AML PATIENTS ACHIEVING FIRST COMPLETE REMISSION AFTER TWO INDUCTION COURSES: A STUDY FROM THE ALWP/EBMT
by: A. Nagler, et al.
Published: (2022-06-01)

Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT
by: Maria H. Gilleece, et al.
Published: (2021-05-01)

Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond
by: Adriana Balduzzi, et al.
Published: (2022-02-01)

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
by: Peter Cuthbertson, et al.
Published: (2021-08-01)